Invasive and Non-Invasive Diagnostic Pathways in the Diagnosis of Cardiac Amyloidosis

被引:6
|
作者
Briasoulis, Alexandros [1 ]
Bampatsias, Dimitrios [1 ]
Papamichail, Adamantia [1 ]
Kuno, Toshiki [2 ]
Skoularigis, John [3 ]
Xanthopoulos, Andrew [3 ]
Triposkiadis, Filippos [3 ]
机构
[1] Natl & Kapodistrian Univ Athens, Alexandra Hosp, Fac Med, Amyloidosis Ctr,Dept Clin Therapeut, 80 Vasilissis Sophias Ave, Athens 11528, Greece
[2] Montefiore Med Ctr, Bronx, NY 10467 USA
[3] Univ Hosp Larissa, Dept Cardiol, Larisa 41110, Greece
关键词
cardiac amyloidosis; diagnosis; AL; ATTR; endomyocardial biopsy; EXTRACELLULAR VOLUME FRACTION; LIGHT-CHAIN AMYLOIDOSIS; SALIVARY-GLAND BIOPSY; AL; PROGNOSIS; FEATURES; STRAIN;
D O I
10.3390/jcdd10060256
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
The appropriate diagnosis and subtyping of cardiac amyloidosis (CA) is frequently missed or delayed due to its vague presentation, clinical overlapping, and diagnostic pitfalls. Recent developments in both invasive and non-invasive diagnostic techniques have significantly changed the diagnostic approach of CA. With the present review, we aim to summarize the current diagnostic approach of CA and to underline the indications of tissue biopsy, either surrogate site or myocardial. The most important factor for timely diagnosis is increased clinical suspicion, especially in certain clinical scenarios. Appropriate imaging with echocardiography or cardiac magnetic resonance (CMR) can provide significant evidence for the diagnosis of CA. Importantly, all patients should undergo monoclonal proteins assessment, with these results significantly determining the steps to follow. A negative monoclonal protein assessment will lead to a non-invasive algorithm which, in combination with positive cardiac scintigraphy, can establish the diagnosis of ATTR-CA. The latter is the only clinical scenario in which the diagnosis can be established without the need of biopsy. However, if the imaging results are negative but the clinical suspicion remains high, a myocardial biopsy should be performed. In the case of the presence of monoclonal protein, an invasive algorithm follows, first by surrogate site sampling and then by myocardial biopsy if the results are inconclusive or prompt diagnosis is needed. The role of endomyocardial biopsy, even though limited by current advances in other techniques, is highly valuable in selected patients and is the only method to reliably establish a diagnosis in challenging cases.
引用
收藏
页数:13
相关论文
共 50 条
  • [1] Cardiac amyloidosis: non-invasive diagnosis
    Hotta, Viviane Tiemi
    Pinto Giorgi, Maria Clementina
    Fernandes, Fabio
    Donadio Abduchl, Maria Cristina
    Gomes Marinho Falcao, IlAndrea Maria
    Mady, Charles
    REVISTA DA ASSOCIACAO MEDICA BRASILEIRA, 2020, 66 (03): : 345 - 352
  • [2] The role of echocardiography in the non-invasive diagnosis of cardiac amyloidosis
    Cacciapuoti F.
    Journal of Echocardiography, 2015, 13 (3) : 84 - 89
  • [3] Multimodality non-invasive imaging diagnosis of cardiac amyloidosis
    Groba-Marco, M.
    Cardenes-Leon, A.
    Garcia-Quintana, A.
    Blanco-Nuez, M.
    Menduina-Gallego, I.
    Mendoza-Lemes, H.
    Hernandez-Ramirez, J.
    Sakhrani-Gobind, R.
    Quevedo-Nelson, V.
    Marin-Esmenota, J. D.
    Garcia-Salvador, J.
    Valeron-Hernandez-Abad, D.
    Caballero-Dorta, E.
    EUROPEAN JOURNAL OF HEART FAILURE, 2017, 19 : 92 - 92
  • [4] A review of the criteria for non-invasive diagnosis of cardiac transthyretin amyloidosis
    Rezk, Tamer
    Fontana, Marianna
    Gillmore, Julian D.
    EXPERT OPINION ON ORPHAN DRUGS, 2021, 9 (03): : 87 - 94
  • [5] Cardiac amyloidosis: non-invasive diagnosis and current treatment strategies
    Lodge, F. M.
    Dubrey, S. W.
    Collinson, J.
    Prasad, S. K.
    BRITISH JOURNAL OF HOSPITAL MEDICINE, 2010, 71 (04) : 230 - 231
  • [6] Senile cardiac amyloidosis: Clinical manifestations and non-invasive diagnostic approach
    Varvarousis, Dimitrios
    Polytarchou, Kali
    Daskalopoulos, Nikolaos
    Mantas, Ioannis
    HELLENIC JOURNAL OF CARDIOLOGY, 2017, 58 (01) : 60 - 64
  • [7] New pathological insights into cardiac amyloidosis: implications for non-invasive diagnosis
    Leone, Ornella
    Longhi, Simone
    Quarta, Candida C.
    Ragazzini, Teresa
    De Giorgi, Lucilla Badiali
    Pasquale, Ferdinando
    Potena, Luciano
    Lovato, Luigi
    Milandri, Agnese
    Arpesella, Giorgio
    Rapezzi, Claudio
    AMYLOID-JOURNAL OF PROTEIN FOLDING DISORDERS, 2012, 19 (02): : 99 - 105
  • [8] Non-invasive predictors of survival in cardiac amyloidosis
    Kristen, Arnt V.
    Perz, Jolanta B.
    Schonland, Stefan O.
    Hegenbart, Ute
    Schnabel, Philipp A.
    Kristen, Joern H.
    Goldschmidt, Hartmut
    Katus, Hugo A.
    Dengler, Thomas J.
    EUROPEAN JOURNAL OF HEART FAILURE, 2007, 9 (6-7) : 617 - 624
  • [9] Non-invasive diagnosis of cardiac amyloidosis due to transthyretin. Case report
    Povar Echeverria, M.
    Auquilla Clavijo, P. E.
    Escobedo Palau, J. A.
    Navarro Beltran, P.
    Povar Marco, J.
    ANALES DEL SISTEMA SANITARIO DE NAVARRA, 2018, 41 (02) : 263 - 267
  • [10] Diagnostic utility of tissue biopsy in transthyretin cardiac amyloidosis diagnosed by non-invasive diagnostic criteria
    Nishi, M.
    Yamada, T.
    Takashio, S.
    Tsujita, K.
    EUROPEAN HEART JOURNAL, 2019, 40 : 495 - 495